Skip to content

Re-evaluation of the muscle-full effect during continuously elevated amino acid availability in healthy young males

Re-evaluation of the muscle-full effect during continuously elevated amino acid availability in healthy young males - Muscle-full study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57267
Enrollment
12
Registered
2024-06-13
Start date
2025-05-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle anabolism Muscle growth

Interventions

Infusion of amino acids

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Male sex - Age between 18 and 35 y inclusive - BMI between 18.5 and 30 kg/m2 - Having given informed consent

Exclusion criteria

Exclusion criteria: - Smoking - Involved in progressive exercise - History of neuromuscular problems - Use of anticoagulants - Recent participation in amino acid tracer infusion studies - Use of medication that affects (muscle) protein metabolism (e.g.corticosteroids, NSAIDs, acne medication) - Phenylketonuria - Diagnosed with/history of liver damage - Diagnosed with/history of severe kidney damage and/or malfunction - Diagnosed with the inability to break down amino acids

Design outcomes

Primary

MeasureTime frame
Post-prandial muscle protein synthesis rates (0-8 h)

Secondary

MeasureTime frame
Muscle protein synthesis (0-2h interval, 2-4h interval, 4-6h interval, 6-8h interval) Plasma glucose, plasma insulin, plasma amino acids, plasma amino acid concentrations, Whole-body protein kinetics (total rate of appearance, exogenous rate of appearance, endogenous rate of appearance, rate of disappearance), Whole-body protein metabolism (synthesis, breakdown, oxidation, net balance) Relevant muscle protein signalling

Countries

Netherlands

Contacts

Public ContactL.J.C. van Loon

Universiteit Maastricht

l.vanloon@maastrichtuniversity.nl+31 433881397

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)